Australian Doctor 8th Nov Issue | Page 36

36 HOW TO TREAT : MATURITY-ONSET DIABETES OF THE YOUNG

36 HOW TO TREAT : MATURITY-ONSET DIABETES OF THE YOUNG

8 NOVEMBER 2024 ausdoc . com . au
syndromes associated with multisystem
dysfunction ( for example , Wolfram syndrome , where youth-onset
diabetes is associated with progressive optic atrophy ). 4 In most cases of MODY , only one copy of a
gene carries the mutation . This is
because two normal copies of these
particular genes are required for
healthy pancreatic function , like
two functional wheels on a bicycle
( see figure 2 ). This is known as
haploinsufficiency .
For haploinsufficient genes , like
most of those associated with MODY ,
when one copy of a gene contains a loss-of-function mutation , the amount of normal product generated
by the single normal gene is insufficient
for healthy function , and so ,
like losing one wheel on a bicycle ,
mutation of a single allelic copy prevents
it from doing its normal job .
Mutations in different individual
genes have been demonstrated to be
associated with MODY ( representing the 14 currently known MODY subtypes ). The most common causes of MODY are mutations in hepatocyte nuclear factor 1-alpha ( HNF1A ), HNF1B , HNF4A , and glucokinase ( GCK ) genes ( see table 1 ). 4
Figure 1 . Pregnant woman using lancing device for blood glucose monitoring .
Diabetes is always caused by the failure of insulin-dependent pathways to control blood glucose levels .
over 1-4 weeks , associated with the classical symptomatic triad of poly­
In MODY , diabetes is caused by a de novo or inherited loss-of-function mutation that impacts the ability
dipsia , polyuria and unintentional weight loss . 4
In at least a quarter of cases ,
of beta cells ( see figure 3 ) to gen­
ketoacidosis is the presenting fea­
erate sufficient insulin to maintain healthy blood glucose levels . 4 Some of the known mutations that cause
ture of type 1 diabetes , particularly in young patients . 19
In contrast , the symptomatic pres­
MODY impair the function of genes
entation of diabetes in MODY is often
involved in beta cell development ,
mild and nonspecific ; ketoacidosis
maturation and endowment at birth .
is uncommon as substantial beta cell
Some of these mutations reduce
function is retained at diagnosis . As a
insulin production and secretion by
result , the first presentation of diabe­
beta cells ( see table 1 ).
tes is more similar to that of a youth
For example , mutations in HNF1A
onset of type 2 diabetes ( the ‘ maturity
gene ( the single most common
onset diabetes ’ in MODY ).
cause of MODY in European popu­
In contrast to type 2 diabetes ,
lations , also known as the MODY3
patients with MODY are often less
subtype ) cause diabetes by lowering
overweight or obese than those pre­
the amount of insulin made by the pancreas . 4 Other mutations interfere with the sensing of glucose lev­
senting with type 2 diabetes . However , the high prevalence of obesity in the general population , even at a young
els in the blood and the triggering
age , reduces the discriminating power
of proportionate insulin release . Finally , some of the mutations that cause MODY result in cellular stress ,
of this clinical association . Moreover , youth-onset type 2 diabetes is also increasingly common , particularly in
accelerated senescence and apopto­
people from South Asia and the Mid­
sis of beta cells . The genetic cause
dle East , in whom pathogenic adipos­
of MODY is unknown in approxi­
ity may be less obvious . 9
mately one in five cases in Western
Weight loss associated with chronic
populations . 4
glycosuria can also confound the clin­
Despite the established link
ical presentation of type 2 diabetes ,
between a loss of function gene
and MODY3 may independently exac­
mutation and the onset of diabetes in
erbate glycosuria ( see table 2 ).
MODY , it is now clear that not every
It has been suggested that the
individual with a mutated copy develops diabetes . This is known as incomplete or reduced penetrance and is in part related to the specific
Figure 2 . Haploinsufficiency : for some genes , two healthy copies are required for normal pancreatic function .
absence of stigmata of insulin resistance ( for example , acanthosis nigricans [ see figure 4 ], excess skin tags ) may help discriminate MODY
gene affected and the position of this
from type 2 diabetes , although many
mutation . For example , almost all
the penetrance is much higher ,
suggests that up to one in five of all
may first present with diabetes in
patients with type 2 diabetes do not
( 89 – 97 %) of individuals with MODY2 eventually have elevated blood glucose levels .
reflecting the negative impact of other co-inherited genes and shared lifestyle factors .
cases of type 2 diabetes in Greenland are linked to a single nucleotide mutation of HNF1A . 18
adulthood when over 35 . 12 However , there may be substantial variation in severity and age of
have these signs . Another key feature is that many individuals with MODY have a strong
In contrast , the penetrance of MODY3 in unselected individuals is less . 12 For example , in one survey , even in unrelated individuals
It is also important to add that changes in the function of many of these same genes are also implicated in other forms of diabetes . For
PRESENTATION
BOX 1 lists some of the clinical features that may raise suspicion of
onset ( known as variable expressivity ) depending on the specific gene ( see table 1 ) and the region of that gene that is mutated , as well as other
family history of diabetes ( as MODY is usually inherited in an ‘ autosomal dominant ’ fashion ) across consecutive generations . Some guidelines use the
with exactly the same mutation in
example , some of the genes associ­
MODY in a youth or young adult diag­
factors including BMI , ethnicity , diet ,
presence of a positive family history
the same MODY3 gene , at least half of the carriers remained diabetes free at 23 years , a third were diabe­
ated with monogenic diabetes are also linked to autoimmune type 1 diabetes .
nosed with diabetes . Most people with MODY first present with diabetes at a young age ( the
environment , lifestyle and genetics . The initial presentation of diabetes in patients with MODY is usu­
as an essential diagnostic criterion for MODY . 4 However , many people with type 1 diabetes or type 2 diabetes also
tes free at 33 years , and 13 % were
Equally , some variants of HNF1A
‘ Y ’ in MODY ). The average age of
ally much less acute than with type 1
have a family history of diabetes ( for
diabetes free even at 50 years . 16 However , in patients with a family history of established or possible MODY ( that is , youth onset diabetes ),
( the MODY3 gene ) are also associated with the development of type 2 diabetes at an earlier age , and onset at a lower BMI . 17 Recent research onset of diabetes is under 20 for most forms of MODY ; however , the onset in individuals under 10 , unlike type 1 diabetes , is rare . 4 Up to 20 % of cases diabetes , as the destruction of beta cells is less fulminant and absolute in MODY . Type 1 diabetes usually presents as an acute illness that evolves different polygenic reasons ), especially those with non-obese type 2 diabetes , with the latter most often confused with MODY . At PAGE 38